| Reference | 
|---|
Buscetta M, Di Vincenzo S, Miele M, Badami E, Pace E, Cipollina C. Cigarette smoke inhibits the NLRP3 inflammasome and leads to caspase-1 activation via the TLR4-TRIF-caspase-8 axis in human macrophages. FASEB J. 2020;34:1819-1832  pubmed  publisher  
 | 
Shi Y, Wang H, Zheng M, Xu W, Yang Y, Shi F. Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly. FASEB J. 2020;34:208-221  pubmed  publisher  
 | 
Ye Y, Jin T, Zhang X, Zeng Z, Ye B, Wang J,  et al. Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway. Front Cell Neurosci. 2019;13:553  pubmed  publisher  
 | 
Labzin L, Bottermann M, Rodriguez Silvestre P, Foss S, Andersen J, Vaysburd M,  et al. Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection. EMBO J. 2019;38:e101365  pubmed  publisher  
 | 
Zong C, Hasegawa R, Urushitani M, Zhang L, Nagashima D, Sakurai T,  et al. Role of microglial activation and neuroinflammation in neurotoxicity of acrylamide in vivo and in vitro. Arch Toxicol. 2019;:  pubmed  publisher  
 | 
Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. Life Sci. 2019;227:101-113  pubmed  publisher  
 | 
Zhang L, Mosoian A, Schwartz M, Florman S, Gunasekaran G, Schiano T,  et al. HIV infection modulates IL-1β response to LPS stimulation through a TLR4-NLRP3 pathway in human liver macrophages. J Leukoc Biol. 2019;105:783-795  pubmed  publisher  
 | 
Mehto S, Jena K, Nath P, Chauhan S, Kolapalli S, Das S,  et al. The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by Impeding Its Assembly and by Mediating Its Selective Autophagy. Mol Cell. 2019;73:429-445.e7  pubmed  publisher  
 | 
Gomez Lopez N, Romero R, Garcia Flores V, Leng Y, Miller D, Hassan S,  et al. Inhibition of the NLRP3 inflammasome can prevent sterile intra-amniotic inflammation, preterm labor/birth, and adverse neonatal outcomes†. Biol Reprod. 2019;100:1306-1318  pubmed  publisher  
 | 
Faro J, Romero R, Schwenkel G, Garcia Flores V, Arenas Hernandez M, Leng Y,  et al. Inflammation-Induced Intra-Amniotic inflammation induces preterm birth by Activating the NLRP3 inflammasome. Biol Reprod. 2018;:  pubmed  publisher  
 | 
Palazón Riquelme P, Worboys J, Green J, Valera A, Martín Sánchez F, Pellegrini C,  et al. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep. 2018;19:  pubmed  publisher  
 | 
D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M,  et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503  pubmed  publisher  
 | 
Stødle G, Silva G, Tangerås L, Gierman L, Nervik I, Dahlberg U,  et al. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Clin Exp Immunol. 2018;193:84-94  pubmed  publisher  
 | 
Chen L, Huang C, Li Y, Deng W, Mao L, Wu L,  et al. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma. Cell Mol Life Sci. 2018;75:2045-2058  pubmed  publisher  
 | 
Huang C, Chen L, Li Y, Wu L, Yu G, Zhang W,  et al. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36:116  pubmed  publisher  
 | 
Boro M, Balaji K. CXCL1 and CXCL2 Regulate NLRP3 Inflammasome Activation via G-Protein-Coupled Receptor CXCR2. J Immunol. 2017;199:1660-1671  pubmed  publisher  
 |